Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LATITUDE-TIMI 60 trial of losmapimod in acute coronary syndrome
NL-OMON41191Phase 3Active, not recruiting
- Sponsor
- GSK
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute coronary syndrome (ACS) and myocardial infarction (MI) comparing Losmapimod + standard of care with Placebo + standard of care (2 arms). Started Jun 2014; status: active, not recruiting.
02
Drugs
losmapimod
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON41191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41191.